Matches in Wikidata for { <http://www.wikidata.org/entity/Q74272937> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q74272937 description "clinical trial" @default.
- Q74272937 description "ensayu clínicu" @default.
- Q74272937 description "klinisch onderzoek" @default.
- Q74272937 description "клінічне випробування" @default.
- Q74272937 name "PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor TSR-022 and PD-1 Inhibitor Dostarlimab (TSR-042)" @default.
- Q74272937 name "PD-1 Inhibitor Dostarlimab" @default.
- Q74272937 type Item @default.
- Q74272937 label "PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor TSR-022 and PD-1 Inhibitor Dostarlimab (TSR-042)" @default.
- Q74272937 label "PD-1 Inhibitor Dostarlimab" @default.
- Q74272937 prefLabel "PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor TSR-022 and PD-1 Inhibitor Dostarlimab (TSR-042)" @default.
- Q74272937 prefLabel "PD-1 Inhibitor Dostarlimab" @default.
- Q74272937 P1050 Q74272937-048CDDCF-A5DA-4F14-8657-16C5F0BA31F7 @default.
- Q74272937 P1132 Q74272937-4A96F3AF-E498-4D70-987E-B57D631DC59D @default.
- Q74272937 P1476 Q74272937-5658FC8A-A4A7-45D5-B00F-9BF2635B5C5B @default.
- Q74272937 P17 Q74272937-ACF5384E-8A3C-46A1-A329-B534C968FD57 @default.
- Q74272937 P2899 Q74272937-A63ED14C-9049-4E7F-A8EB-9990FFB63102 @default.
- Q74272937 P3098 Q74272937-C45E2589-E220-42F9-94F2-01792F3CB830 @default.
- Q74272937 P31 Q74272937-23503827-FF00-4F5E-B861-584BF34C485D @default.
- Q74272937 P580 Q74272937-D3057046-1789-43E0-9075-EA54EECF1F4B @default.
- Q74272937 P582 Q74272937-E08C9395-259B-40DE-A2BE-E4911C4C63C9 @default.
- Q74272937 P6099 Q74272937-509CEFC2-09D1-45BD-B1DE-194B0C9594CA @default.
- Q74272937 P8363 Q74272937-FECB1D0F-B1AE-4FE7-9C18-F1631BFE5955 @default.
- Q74272937 P1050 Q180614 @default.
- Q74272937 P1132 "+56" @default.
- Q74272937 P1476 "Randomized Phase II Neoadjuvant Study of PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor TSR-022 and PD-1 Inhibitor Dostarlimab (TSR-042) in Resectable Stage III or Oligometastatic Stage IV Melanoma (Neo-MEL-T)" @default.
- Q74272937 P17 Q30 @default.
- Q74272937 P2899 "+18" @default.
- Q74272937 P3098 "NCT04139902" @default.
- Q74272937 P31 Q30612 @default.
- Q74272937 P580 "2019-12-15T00:00:00Z" @default.
- Q74272937 P582 "2022-03-15T00:00:00Z" @default.
- Q74272937 P6099 Q42824440 @default.
- Q74272937 P8363 Q78089383 @default.